Dr. Lal Pathlabs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LALPATHLAB, BSE:539524 Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs Ltd.

04 Dec 2015

3318.10

-1.24%

Dr Lal PathLabs Ltd - IPO Note

IPO Note: Dr. Lal Pathlabs Ltd.

Systematix Group

collected and processed approximately 21.8 million samples from Dr Lal Path Lab serves approximately 9.9 million patients. According to CRISIL Research, the size of the Indian diagnostic healthcare services industry was approximately Rs.377 billion (US$6.0 billion) in Fiscal Year 2015, and it is projected to grow to over Rs.600 billion (US$9.6 billion) by Fiscal Year 2018. We believe that the increasing prescription of diagnostic tests and services by healthcare providers in India, combined with the growing focus on early detection and prevention of chronic and lifestyle diseases, such as diabetes, hypertension, heart disease and cancer, creates a significant market...

Dr. Lal Pathlabs Ltd. is trading above all available SMAs

Dr. Lal Pathlabs Ltd.

30 Nov 2015

3318.10

-1.24%

Dr. Lal Pathlab Ltd.

IPO Subscribe: Dr. Lal Pathlabs Ltd.

Ashika Research

The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of 11,600,000 Equity Shares by the Selling Shareholders. The Company will not receive any proceeds of...

Number of FII/FPI investors decreased from 382 to 358 in Jun 2025 qtr

Is Dr. Lal Pathlabs Ltd. worth buying?

226 Votes:

Buy 76.11%

Sell 14.6%

Hold 9.29%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf